What Happened
A traveling nurse assigned to nursing and rehabilitation facilities across Massachusetts was caught diverting morphine from patients by diluting bottles she was responsible for administering, and was sentenced to federal prison.
The nurse had practiced for over 30 years, licensed in both New Hampshire and Massachusetts. In 2021, she voluntarily surrendered her New Hampshire license following an investigation into allegations that she had tampered with morphine bottles at a rehabilitation center in Derry, New Hampshire, but continued practicing under her Massachusetts license. From December 2021 through at least May 2022, working as a traveling nurse through a healthcare staffing company, she was assigned to various Massachusetts nursing and rehabilitation facilities. Several facilities began to suspect diversion because of her consistent access to morphine bottles and evidence of tampering — bottles leaking or appearing to be the wrong color.
At a rehabilitation center in Danvers, a nurse noticed a wet, leaking morphine bottle in April 2022, and administrators identified three additional bottles with signs of tampering. Laboratory tests confirmed all were diluted. Law enforcement then ran a controlled operation: before her May 12, 2022 shift, investigators photographed the morphine bottles on the cart assigned to her, including one sealed bottle. She was the only person with access to that cart for her entire shift. Afterward, the previously sealed bottle was found to be a different color, leaking, and showed evidence of tampering. She pleaded guilty in November 2024 to tampering with a consumer product and was sentenced on April 4, 2025 to three months in prison, followed by two years of supervised release during which she is barred from practicing as a registered nurse or working anywhere with access to controlled substances.
What Went Wrong
A nurse with a documented prior tampering investigation in one state continued practicing and diverting medication in another. Key failure points:
- License surrender in one state did not stop practice in another. Nursing license databases and disciplinary actions were not shared or checked across state lines before she was hired to work with controlled substances in Massachusetts.
- Staffing agency placement lacked scrutiny. A healthcare staffing company assigned her to multiple facilities without apparently verifying her full disciplinary history, including the New Hampshire surrender.
- Diluted bottles were only caught by chance. The pattern was discovered because a bottle happened to be visibly leaking, not through routine weight or concentration testing of controlled substance stock.
- Detection required a covert operation. Facilities needed to stage a controlled sting to confirm the diversion, indicating no less-invasive detection method — like routine tamper-evident packaging checks — was already in place.
How It Could Have Been Prevented
- Check the National Practitioner Data Bank and all state nursing board disciplinary records — not just the state of current licensure — before placing traveling or contract nurses.
- Require staffing agencies to disclose license surrenders, investigations, and disciplinary history in any state as a condition of placement.
- Perform routine weight or concentration testing of liquid controlled substances, particularly for staff with recent unexplained access patterns.
- Use tamper-evident packaging and train staff to visually inspect bottle color, seal integrity, and fill level before every administration.
- Track which staff member had exclusive access to specific medication carts during periods when tampering is suspected, to narrow investigations quickly.
Related Guidance
- Employee Screening & Fitness for Duty — Vetting standards for staff with controlled-substance access, including travel and contract staff.
- Diversion prevention checklist — Self-assessment for nursing and rehabilitation facilities.
- 15 Red Flags of Drug Diversion — Behavioral and transactional indicators of diversion by clinical staff.
- Investigation Playbook — How to run an internal diversion investigation when staff or product integrity is questioned.
- Patient Notification After Drug Diversion — When and how to notify potentially exposed patients.